1-11948023-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_000302.4(PLOD1):c.124C>T(p.Arg42Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000224 in 1,613,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R42H) has been classified as Uncertain significance.
Frequency
Consequence
NM_000302.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000915 AC: 23AN: 251494Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135922
GnomAD4 exome AF: 0.000242 AC: 354AN: 1461678Hom.: 0 Cov.: 30 AF XY: 0.000243 AC XY: 177AN XY: 727148
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74320
ClinVar
Submissions by phenotype
not provided Uncertain:3
Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function -
- -
PLOD1, Exon 2, c.124C>T (p.Arg42Cys) - Heterozygous (NM_000302.3) Chromosome location 1:12008080 C / T Testing was conducted at Invitae laboratory. The PLOD1 gene is associated with autosomal recessive Ehlers-Danlos syndrome, kyphoscoliotic form (MedGen UID: 75672). Our patient has not been diagnosed with this condition. We classify this as a Variant of Uncertain Significance (VUS). Because Ehlers-Danlos syndrome, kyphoscoliotic form, is autosomal recessive, any single variant is not expected to cause disease. This variant has not been reported in the literature in association with disease. It has not yet been reported to ClinVar. There are no missense variants listed in ClinVar as Likely Pathogenic or Pathogenic within 10 amino acids of this codon. Of note, the variants in this gene that are classified in ClinVar as Pathogenic are predominantly truncating: nonsense, frameshift, and splice site variants—and are not missense variants like this one. The Arginine at codon 42 is conserved across mammals but is poorly conserved across other vertebrate species. Cysteine is not the default amino acid in any species. This is a nonconservative amino acid change, from a positively-charged Arginine to a polar Cysteine capable of forming disulfide bridges. According to the Invitae report, algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant is present in 25 out of 140,000 individuals in gnomAD, for an overall MAF of 0. 009%. The highest MAF is among individuals with non-Finnish European ancestry: 0.01657% (21/126,728 alleles). -
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
The p.R42C variant (also known as c.124C>T), located in coding exon 2 of the PLOD1 gene, results from a C to T substitution at nucleotide position 124. The arginine at codon 42 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Ehlers-Danlos syndrome, kyphoscoliotic type 1 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 42 of the PLOD1 protein (p.Arg42Cys). This variant is present in population databases (rs202003686, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with PLOD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 459806). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PLOD1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at